- Home
- LPAA vs CADL Comparison
LPAA vs CADL Comparison
Compare LPAA & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$6.46
Company Overview
Basic Information| Metric | LPAA | CADL |
|---|---|---|
| Founded | 2024 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.3M | 339.8M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LPAA | CADL |
|---|---|---|
| Price | $10.64 | $6.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $19.43 |
| AVG Volume (30 Days) | 40.5K | ★ 703.4K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $31.91 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.06 | $4.25 |
| 52 Week High | $10.70 | $13.68 |
Technical Indicators
Market Signals| Indicator | LPAA | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 70.11 | 64.30 |
| Support Level | $10.57 | $5.88 |
| Resistance Level | $10.61 | $6.34 |
| Average True Range (ATR) | 0.02 | 0.35 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 71.43 | 99.56 |
Price Performance
Historical Comparison LPAA
CADL
About LPAA Launch One Acquisition Corp. Class A Ordinary shares
Launch One Acquisition Corp is a blank check company.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.